Only two cases of chronic hiccups tied to eosinophilic esophagitis have previously been reported, the man's doctors say.

Over 50% of the current literature on EoE has been published in the last 3 years, signaling both a rising incidence and increased recognition of this disorder. Treatment options available for ...

While treatment of EoE is complicated by a number of different factors, consensus would support that symptom reduction/resolution should be a primary goal in the care of patients by practicing ...

Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory disease of undetermined pathophysiology that results in dense mucosal eosinophilia and esophageal dysfunction. In childhood ...

This page compiles essential information on generic and brand-name drugs specifically used for Eosinophilic Esophagitis (EoE) treatment.Here, you can explore dosages, prices, side effects ...

The most common challenge in EoE management was patient adherence to treatment, reported 76% of the clinicians. Adherence was better in pharmacological treatments, as 87% of clinicians said they ...

The following tests can help rule out other possible causes of symptoms and confirm an EoE diagnosis: Treatment for ...

What are the best treatment options for managing my symptoms and preventing long-term complications? How can I tell the difference between a flare-up of EoE symptoms and another condition ...

Eupraxia's approach, which focuses on localized, extended-release drug delivery, aims to reduce adverse events and improve treatment outcomes. Alongside the EoE treatment, the company is also ...

Eupraxia’s approach, which focuses on localized, extended-release drug delivery, aims to reduce adverse events and improve treatment outcomes. Alongside the EoE treatment, the company is also ...

EoE is an inflammatory-mediated disease in which white blood cells migrate into and become trapped in the esophagus, creating pain and difficulty with swallowing food. The Company's ongoing ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company specializing in precision local drug delivery, today announced additional ...